First Trust Advisors
TARS icon

First Trust Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

First Trust Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Sell
117,811
-5,100
-4% -$326K ﹤0.01% 1354
2026
Q1 		$8.62M Buy
122,911
+11,141
+10% +$778K 0.01% 1161
2025
Q4 		$9.15M Buy
111,770
+59,873
+115% +$4.47M 0.01% 1141
2025
Q3 		$3.08M Sell
51,897
-53,193
-51% -$2.62M ﹤0.01% 1631
2025
Q2 		$4.26M Buy
+105,090
New +$4.73M ﹤0.01% 1437

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

First Trust Advisors's TARS Position: Q2 2026 in Review

First Trust Advisors reduced its Tarsus Pharmaceuticals (TARS) stake by 4.1% in Q2 2026, selling an estimated $326K and leaving 117,811 shares worth $7.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

First Trust Advisors first reported a position in TARS in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.15M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • First Trust Advisors held 117,811 shares of Tarsus Pharmaceuticals worth $7.42M as of Q2 2026.
  • First Trust Advisors sold 5,100 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $326K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1354 holding.
  • First Trust Advisors first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • First Trust Advisors's Tarsus Pharmaceuticals position peaked at $9.15M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.